Evergreen Theragnostics Opens Phase II Small Cell Lung Cancer Clinical Trial in EU
The CCK2-VIEW trial uses 68Ga-EVG321, a peptide-based Radioligand imaging agent administered to patients with small cell lung cancer.
European Union | 18/10/2024 | By Aishwarya
Union Health Secretary Explores Vaccine Collaboration at Bilthoven Biologicals in Netherlands
The focus centered on enhancing partnership and cooperation in the production of vaccines, addressing critical issues related to pandemic preparedness.
European Union | 29/04/2024 | By Abha | 107
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy